Month: March 2022

Q4 Recurring Revenue from Royalties and Interest of $ 1,605,980; YTD $6,091,103 — YoY growth of 13.4% TORONTO, Ontario, March 31, 2022 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”) announces its unaudited financial and operating results for the three-months (“Q4 2021) and year ended December 31, 2021 (“YE 2021”). 2021 Performance HighlightsBook value of approximately $0.75 per share; YoY growth of 33.7%. Net income of $ 2,263,807 in Q4 2021, compared to a net loss of $(1,040,381) in Q4 2020. YTD net income of $5,597,275; YoY growth of 164%. Recurring revenue from Royalties and Interest of $ 1,605,980 in Q4 2021; YTD recurring revenue of $6,091,103; YoY growth of 13.4%. Total revenue under IFRS of $3,342,968 in Q4 2021; YTD revenue of $10,426,947; a slight year-over-year (YoY) growth of 0.5%.In YE2021,...

Revenue increased 38% to $31.1 million in 2021 vs. $22.5 million in 2020 Net income from continuing operations of $16.0 million vs. $2.1 million in 2020 Adjusted EBITDA increased 68% to $5.8 million in 2021 vs. $3.4 million in 2020 Continued expansion of managed portfolio through acquisition and investment in two mixed-use, transit-oriented, luxury high-rise apartment assets in Rockville, Md.RESTON, Va., March 31, 2022 (GLOBE NEWSWIRE) — Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock”) announced results today for its fiscal year ended December 31, 2021. “Comstock’s 2021 was highlighted by growth of assets under management, revenue, and earnings,” said Christopher Clemente, Chairman and CEO. “The premium assets in our Anchor Portfolio continue to provide a foundation for positive top and bottom-line results. Our...

Company Plans to Initiate Phase 3 Study for TMB-001 in Q2 2022 BASKING RIDGE, NJ, March 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the fourth quarter and year ended December 31, 2021. John Koconis, Chairman and Chief Executive Officer of Timber, commented, “Timber achieved multiple milestones over the past few months. In October, we reported positive topline data for our lead asset TMB-001 and just a few weeks ago, we had a productive follow-up meeting with the FDA, positioning us to launch a Phase 3 study in the second quarter...

EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for the year ended December 31, 2021, a period defined by growth, expansion and maturity, and provided an update on business activities. 2021 Highlights:Validated results of subsidiary Helomics’ Discovery 21 proof of concept of its PeDAL® platform, demonstrated ability to make high-confidence predictions in ovarian tumor samples. Added new revenue stream, synergistic customer base and disruptive technology through acquisition of zPREDICTA, Inc., a company pioneering tumor-specific in vitro 3D cell culture models for drug discovery and development. Expanded strategic sales and business development...

WOOD DALE, Ill., March 31, 2022 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced fourth quarter and full year 2021 financial results. Fourth Quarter 2021 Results Sales for the fourth quarter of 2021 were $127.0 million, an increase of $22.0 million, or 21%, versus the comparable period last year. The improvement in sales is comprised of increases of approximately $8.3 million, $7.9 million, and $5.8 million in the transportation, industrial and power systems (formerly energy) end markets, respectively. Higher transportation end market sales were primarily driven by increased sales in the medium duty truck market due to the continued sell down and exhaustion of certain 6.0L...

Provides 2022 Financial Guidance Fourth Quarter 2021 OverviewConsulting Fee Revenue (“CFR”) rose 8.0% to $77.9 million from $72.2 million in the fourth quarter of 2020 New contract awards totaled $162.4 million, producing a book-to-burn ratio of 208.4% Net loss of $2.3 million, or $0.04 per share, compared to net loss of $1.8 million, or $0.03 per share, in last year’s fourth quarter Adjusted net income (a non-GAAP measure) improved to $0.3 million from an adjusted net loss $0.7 million for the same period last year Adjusted EBITDA (a non-GAAP measure) of $5.2 million, compared to $5.7 million in the fourth quarter 2020Full Year 2021 OverviewCFR rose to $305.1 million from $296.6 million in 2020 New contract awards totaled $436.9 million, producing a book-to-burn ratio of 143.2% Net loss narrowed to $4.3 million, or $0.07 per...